StockData
West Pharmaceutical Services Inc logo

West Pharmaceutical Services Inc (WST) stock

WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3032% above fair value
$416.42+5.12 (+1.24%)

Close on Nov 13, 2026Market cap $29.01BP/E 46.7Yield 0.21%

West Pharmaceutical Services statistics

115 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Feb 11, 2027 (estimated, before the open)
Last ex-dividend date
Jul 29, 2026
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$29.01B
$498.53M
Enterprise Value
$28.75B
$433.11M
PE Ratio
46.74
29.52
PS Ratio
8.54
2.94
PB Ratio
9.77
3.24
P/TBV Ratio
10.17
4.81
P/FCF Ratio
63.98
26.31
P/OCF Ratio
44.32
21.97

Enterprise valuationIndustry

EV / Sales
8.46
2.60
EV / EBITDA
29.81
18.41
EV / EBIT
36.85
24.14
EV / FCF
63.40
27.51

Share statisticsIndustry

Shares Outstanding
70M
43M
Shares Change (YoY)
-1.48%
3.32%
Shares Change (QoQ)
-0.85%
0.20%
Float
69M
37M
Shares Held by Insiders
0.66%
10.5%
Shares Held by Institutions
101.2%
60.5%

Short sellingIndustry

Short Interest
2M
–
Short Interest Change
-10.2%
-2.57%
Short % of Float
2.61%
5.11%
Short % of Shares Outstanding
2.59%
3.98%
Days to Cover
2.34
3.94

Stock price statisticsIndustry

52-Week High
$438.27
–
52-Week Low
$223.83
–
20-Day Moving Average
$403.02
–
50-Day Moving Average
$380.18
–
200-Day Moving Average
$321.39
–
Average True Range (14)
$10.62
–
Price Change (1 Week)
4.15%
0.99%
Price Change (1 Month)
8.72%
-3.52%
Price Change (3 Months)
20.1%
-7.86%
Price Change (6 Months)
37.5%
-1.12%
Price Change (YTD)
51.3%
-2.92%
Price Change (1 Year)
52.1%
-1.37%
Price Change (3 Years)
19.8%
3.24%
Price Change (5 Years)
-0.67%
-50.4%
Price Change (10 Years)
439.3%
58.9%
Average Volume (10 Days)
728,561
–
Average Volume (20 Days)
764,467
–
Average Volume (90 Days)
644,835
–
Relative Volume
0.74
0.76
Relative Strength Index (14)
65.8
46.7
Volatility (1 Year)
31.4%
64.2%
Beta (5 Years)
1.05
1.04

MarginsIndustry

Gross Margin
37.6%
55.9%
Operating Margin
23.0%
-5.12%
Pretax Margin
23.2%
-2.32%
Profit Margin
18.8%
-9.29%
EBITDA Margin
28.4%
-2.52%
FCF Margin
13.3%
0.65%

Returns on capitalIndustry

Return on Equity (ROE)
21.2%
-17.3%
Return on Assets (ROA)
15.6%
-12.3%
Return on Invested Capital (ROIC)
23.0%
-2.83%
Return on Capital Employed (ROCE)
22.8%
-8.13%

Financial positionIndustry

Current Ratio
2.82
2.49
Quick Ratio
1.88
1.53
Debt / Equity
0.07
0.42
Debt / EBITDA
0.21
2.23
Debt / FCF
0.45
3.62
Net Debt / EBITDA
-0.27
1.49
Interest Coverage
96.32
-1.63

GrowthIndustry

Revenue Growth (YoY)
12.6%
9.42%
Net Income Growth (YoY)
29.9%
13.4%
EPS Growth (YoY)
32.2%
15.1%
FCF Growth (YoY)
19.6%
7.64%
Revenue Growth (3Y CAGR)
2.12%
7.08%
Revenue Growth (5Y CAGR)
7.44%
11.8%
EPS Growth (3Y CAGR)
-4.23%
3.11%
EPS Growth (5Y CAGR)
8.24%
7.64%

EfficiencyIndustry

Asset Turnover
0.83
0.59
Inventory Turnover
4.70
2.20
Revenue Per Employee
$314.51K
$331.99K
Profits Per Employee
$59.16K
-$46.47K
Employee Count
10,800
193
WACC
10.3%
9.91%

Income statement (TTM)Industry

Revenue
$3.40B
$108.17M
Gross Profit
$1.28B
$62.29M
Operating Income
$780.20M
-$3.72M
Pretax Income
$789.40M
-$1.83M
Net Income
$638.90M
-$6.19M
EBITDA
$964.50M
-$1.98M
EPS (Diluted)
$8.91
-$0.11

Balance sheetIndustry

Cash & Short-Term Investments
$464.10M
$38.97M
Total Debt
$202.90M
$96.00M
Net Cash (Debt)
$261.20M
$3.95M
Net Cash Per Share
$3.75
$0.26
Equity (Book Value)
$2.97B
$63.80M
Book Value Per Share
$42.61
$3.26
Tangible Book Value
$2.85B
$11.61M
Working Capital
$1.17B
$57.32M

Cash flow (TTM)Industry

Operating Cash Flow
$654.50M
-$483.87K
Capital Expenditures
-$201.10M
-$3.94M
Free Cash Flow
$453.40M
-$238.00K
FCF Per Share
$6.51
-$0.00

Dividends and yieldsIndustry

Earnings Yield
2.20%
-4.76%
FCF Yield
1.56%
0.28%
Dividend Yield
0.21%
0.79%
Buyback Yield
2.36%
0.80%
Shareholder Yield
2.57%
1.12%
Dividend Per Share
$0.86
$0.72
Dividend Growth (YoY)
4.88%
4.88%
Years of Dividend Growth
17
0
Payout Ratio
9.83%
24.3%
FCF Payout Ratio
13.9%
22.0%

Taxes and interestIndustry

Interest Expense
$8.10M
$5.40M
Income Tax
$168.20M
$1.55M
Effective Tax Rate
21.3%
18.0%

Scores and fair valueIndustry

Graham Number
$92.42
$38.11
Graham Upside
-77.8%
-56.1%
Altman Z-Score
19.41
2.47
Piotroski F-Score
8
5
Beneish M-Score
-2.79
-2.64
Lynch Fair Value
$73.42
–
Lynch Upside
-82.4%
-45.2%

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodWSTS&P 500DifferenceWST per yearS&P 500 per year
1 month+12.0%-3.0%+15.0 pts
3 months+20.3%-2.8%+23.1 pts
Year to date+51.7%+11.5%+40.2 pts
1 year+56.5%+13.5%+43.1 pts
3 years+24.1%+77.7%−53.6 pts+7.5%+21.1%
5 years+0.6%+72.6%−72.0 pts+0.1%+11.5%
10 years+455.9%+308.2%+147.7 pts+18.7%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

2M WST shares were sold short on Oct 30, 2026, down 10.2% from the previous report, or 2.61% of the shares available to trade. At recent volumes it would take 2.3 days to buy them back. Over the last 20 sessions, 43.0% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20261,807,517-10.2%774,0832.3
Oct 15, 20262,013,684-4.2%482,5414.2
Sep 30, 20262,101,162-11.6%674,5393.1
Sep 15, 20262,378,099+8.3%526,9364.5
Aug 31, 20262,195,650+3.4%449,3994.9
Aug 14, 20262,123,261-15.4%516,2614.1
Jul 31, 20262,510,898+6.4%987,2272.5
Jul 15, 20262,360,270+1.9%659,6893.6
Jun 30, 20262,316,731+1.2%994,3582.3
Jun 15, 20262,288,165-1.6%650,3433.5
May 29, 20262,326,364+1.9%690,6743.4
May 15, 20262,282,225-5.9%869,4172.6

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?